MERIGGIOLA, MARIA CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 11.745
AS - Asia 9.560
EU - Europa 7.095
SA - Sud America 577
AF - Africa 526
Continente sconosciuto - Info sul continente non disponibili 491
OC - Oceania 12
Totale 30.006
Nazione #
US - Stati Uniti d'America 11.557
VN - Vietnam 3.375
SG - Singapore 2.236
IT - Italia 1.950
CN - Cina 1.926
GB - Regno Unito 1.382
DE - Germania 794
SE - Svezia 635
HK - Hong Kong 633
FR - Francia 470
BR - Brasile 415
UA - Ucraina 384
IN - India 370
RU - Federazione Russa 353
BD - Bangladesh 260
IE - Irlanda 229
NL - Olanda 224
JP - Giappone 159
KR - Corea 159
TG - Togo 152
ZA - Sudafrica 133
FI - Finlandia 106
CA - Canada 104
BG - Bulgaria 96
EE - Estonia 95
CI - Costa d'Avorio 88
CH - Svizzera 74
AR - Argentina 72
JO - Giordania 71
PH - Filippine 68
SC - Seychelles 66
AT - Austria 49
MX - Messico 46
TH - Thailandia 46
PL - Polonia 42
BE - Belgio 38
ES - Italia 37
TR - Turchia 37
ID - Indonesia 35
NG - Nigeria 34
IQ - Iraq 30
EC - Ecuador 23
RO - Romania 23
SA - Arabia Saudita 22
CZ - Repubblica Ceca 21
CL - Cile 20
GR - Grecia 18
TW - Taiwan 18
PK - Pakistan 17
CO - Colombia 16
MY - Malesia 16
EG - Egitto 14
LT - Lituania 13
UZ - Uzbekistan 13
PT - Portogallo 11
AL - Albania 9
IR - Iran 9
LB - Libano 9
AU - Australia 8
AZ - Azerbaigian 8
KE - Kenya 8
UY - Uruguay 8
VE - Venezuela 8
MD - Moldavia 7
IL - Israele 6
LV - Lettonia 6
MA - Marocco 6
NO - Norvegia 6
PE - Perù 6
PR - Porto Rico 6
TN - Tunisia 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
NP - Nepal 5
PY - Paraguay 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
HN - Honduras 4
KG - Kirghizistan 4
NI - Nicaragua 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
HU - Ungheria 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
SN - Senegal 3
BM - Bermuda 2
CY - Cipro 2
DK - Danimarca 2
HR - Croazia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
Totale 29.483
Città #
Singapore 1.537
Ashburn 1.308
Southend 1.123
Ho Chi Minh City 770
Fairfield 752
Chandler 741
Hanoi 714
Hong Kong 605
Santa Clara 563
San Jose 509
Wilmington 412
Seattle 380
Woodbridge 378
Hefei 327
Houston 325
Dong Ket 311
Bologna 301
Princeton 294
Boardman 286
Beijing 272
Cambridge 259
Jacksonville 243
Ann Arbor 231
Dublin 229
Los Angeles 218
Dallas 188
New York 176
Lauterbourg 158
Milan 153
Lomé 151
Turin 137
Nanjing 135
Tokyo 135
Council Bluffs 126
Seoul 125
Westminster 124
Padova 107
Haiphong 103
Da Nang 95
Sofia 95
Berlin 94
Abidjan 88
Buffalo 87
São Paulo 79
Helsinki 76
Rome 76
Redmond 75
Amman 70
Florence 65
Saint Petersburg 64
Frankfurt am Main 58
Bern 57
Shenyang 56
Atlanta 55
San Francisco 55
Jinan 53
Mülheim 51
San Diego 50
Hải Dương 49
Quận Bình Thạnh 49
Ha Long 45
Munich 45
Phoenix 45
Medford 42
Naples 42
Orem 42
Redondo Beach 42
Shanghai 42
Chicago 40
Guangzhou 39
Nanchang 38
Biên Hòa 37
Denver 35
London 35
Changsha 34
Paris 34
Abeokuta 33
Amsterdam 32
Brooklyn 32
Brussels 32
Montreal 32
Thái Nguyên 32
Vũng Tàu 32
Bengaluru 31
Des Moines 31
Hebei 31
Tianjin 31
Zhengzhou 31
Can Tho 28
Falkenstein 28
Ninh Bình 27
Falls Church 26
Bắc Ninh 25
Mahé 24
Hangzhou 23
Mountain View 23
Verona 23
Bắc Giang 22
Olalla 21
Redwood City 21
Totale 17.711
Nome #
2D and 3D Ultrasound Examination of Labia Minora. 835
Opioid-induced hypogonadism: why and how to treat it. 667
Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome. 478
Long-term cross-sex hormone treatment is safe in transsexual subjects. 403
Safety of hormonal treatment in transgenders. 396
Prevalenza delle disfunzioni sessuali femminili nelle donne in menopausa con sindrome metabolica. 375
A Randomized Double-Blind Placebo-Controlled Pilot Trial on the Effects of Testosterone Undecanoate Plus Dutasteride or Placebo on Muscle Strength, Body Composition, and Metabolic Profile in Transmen 369
Tecniche di Riproduzione Assistita. 349
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men 340
Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen. 322
A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen 303
Fetal cardiac defects and third-trimester maternal serum placental growth factor 280
Endocrine care of transpeople part II. A review of cross-sex hormonal treatments, outcomes and adverse effects in transwomen. 280
Menopause affects pain depending on pain type and characteristics. 269
Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy 262
Prevalence of Sexual Dysfunction among Postmenopausal Women with and without Metabolic Syndrome. 256
Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration. 248
Completeness of exercise reporting among randomized controlled trials on pelvic floor muscle training for women with pelvic organ prolapse: A systematic review 248
Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. 247
Effects of Three Different Testosterone Formulations in Female-to-Male Transsexual Persons. 242
Reply to the Letter to the Editor: How Does Sleep Relate to Metabolic Syndrome in Women with Sexual Dysfunction? 240
Androgen receptor expression in the human vagina under different physiological and treatment conditions 237
Neonatal hypoxic-ischemic encephalopathy in apparently low risk pregnancies: retrospective analysis of the last five years at the University of Bologna. 230
Ginecologia e Ostetricia. Seconda Edizione. 230
Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men. 227
SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people 219
Bone health in transgender people: a narrative review 219
Effects of long term high-dose testosterone administration on vaginal epithelium structure and estrogen receptor a and b expression of young women. 218
Body imaging and sexual behavior in lean women with polycystic ovary syndrome. 216
Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. 216
Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate. 215
The impact of hormonal replacement treatment in postmenopausal women with uterine fibroids: A state-of-the-art review of the literature 210
A novel circulating hormone of testis origin in humans 209
Bone mineral density, body composition and metabolic profiles in adult women with complete androgen insensitivity syndrome and removed gonads using oral or transdermal estrogens 209
Le malformazioni vaginali 208
Cervical length and risk of antepartum bleeding in women with complete placenta previa 208
Cross-sex hormone administration changes pain in transsexual women and men. 206
L'alterazione della funzione sessuale ha ripercussioni significativamente inferiori sul benessere psicofisico delle donne in menopausa rispetto alle donne in premenopausa. 206
Hormonal replacement therapy in menopausal women with history of endometriosis: A review of literature 206
Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. 205
Testosterone decreases adiponectin levels in female to male transsexuals 203
Effetti metabolici della somministrazione di testosterone nei soggetti FtM (female to male) affetti da disforia di genere (D.I.G.). 203
Effect of long-term testosterone administration on the endometrium of female to male (FtM) transsexuals. 202
Prevalence of metabolic syndrome and its components in women with and without pelvic organ prolapse and its association with prolapse severity according to the Pelvic Organ Prolapse Quantification system. 199
Somministrazione di noretisterone enantato in combinazine con testosterone undecanoato per la contraccezione maschile 198
A placebo controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effects on anthropometric, metabolic and biochemical parameters 197
The impairment of sexual function is less distressing for menopausal than for premenopausal women. 196
L'influenza della menopausa sulle caratteristiche della cefalea. 195
Changes in Vaginal Physiology of Menopausal Women with Type 2 Diabetes 195
Valutazione dell'influenza dell'accesso chirurgico sulla sessualità nella donna isterectomizzata. 190
Vaginal Health in Menopausal Women 190
Effects of ospemifene on vaginal epithelium of post-menopausal women. 189
Short-term modification of sex hormones is associated with changes in ghrelin circulating levels in healthy normal-weight men. 187
Problematiche endocrine della disforia di genere 187
Laparoscopic surgery for benign adnexal conditions under spinal anaesthesia: Towards a multidisciplinary minimally invasive approach 187
Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness 186
Androgens and male contraception 186
A prospective study on sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery. 184
Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women 184
Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment 181
10th summit meeting consensus: recommendations for regulatory approval for hormonal male contraception. 181
Hysterectomy and Bilateral Salpingoovariectomy in a Transsexual Subject without Visible Scaring. 181
Carotid intima-media wall thickness is increased in FtM transsexuals treated with testosterone compared to normal control women. 179
Transvaginal Ultrasound and Doppler Features of Intraligamental Myomas 178
Contraccezione maschile: stato dell'arte. 176
Testosterone Undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male (FtM) transsexuals: hormonal and metabolic effects. 176
Bone Mineral Density in Women Living with Complete Androgen Insensitivity Syndrome and Intact Testes or Removed Gonads. 175
Chest Wall Masculinization in Female-to-Male Transsexuals: Our Treatment Algorithm and Life Satisfaction Questionnaire 174
Knowledge of genito-urinary syndrome of menopause among Italian gynecologists: the DIADEM survey 174
Update on male hormonal contraception 173
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis 172
Structure of Epithelial and Stromal Compartments of Vulvar and Vaginal Tissue From Women With Vulvo-Vaginal Atrophy Taking Ospemifene. 172
Contraception across transgender 172
Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results 171
Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. 171
Mental Health and Endocrine Telemedicine Consultations in Transgender Subjects During the COVID-19 Outbreak in Italy: A Cross-Sectional Web-Based Survey 169
Accettabilita' e assenza di effetti sull'umore, sul comportamento e sulla funzione sessuale di un regime contraccettivo ormonale maschile 168
Reproductive and non-reproductive effects of testosterone undecanoate (TU) plus cyproterone acetate (CPA) or norethisterone enanthate (NETE) for male contraception. 165
Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment 165
Stratified analysis of health and gender-affirming care among Italian transgender and gender diverse adults 164
Chest-wall contouring in female to male transsexuals 164
Laparoscopic treatment of interstitial twin pregnancy. 162
Feasibility and safety of two different surgical routes for the eradication of recto-vaginal endometriosis with vaginal mucosa infiltration (Endo-Vag-r study) 162
Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study 160
Advances in male hormonal contraception. 160
Estrogens and testosterone change pain incidence and characteristics in MtF and FtM transsexuals. 158
Childhood maltreatment in subjects with male-to-female gender identity disorder. 158
Testosterone al femminile. 158
Effects of Testosterone Undecanoate (TU) Administered Alone or in Combination with Letrozole or Dutasteride in Female to Male (FtM) Transsexuals. 156
Effect of different testosterone formulations on body weight, body composition and metabolism in Female to Male (FtM) transsexuals. 154
Complete androgen insensitivity syndrome: From bench to bed 154
Repeated intramuscular injections of testosterone undecanoate (TU) in FtM transsexuals. 153
Prevalence and Psychopathological Determinants of Sexual Dysfunction and Related Distress in Women With and Without Multiple Sclerosis 152
Feminization of the face in male to female transsexuals 151
Small Variations in Crucial Steps of Tunel Assay Coupled to Flow Cytometry Greatly Affect Measures of Sperm DNA Fragmentation. 149
Feasibility, safety, and satisfaction of combined hysterectomy with bilateral salpingo-oophorectomy and chest surgery in transgender and gender non-conforming individuals 148
Effects of testosterone undecanoate (TU) administered alone or in combination with letrozole or dutasteride in female to male transsexuals (FtM): 147
Male hormonal contraception: a double-blind placebo-controlled study. 146
Sexual counterpart of hormonal male contraception. 145
The COVID-19 Pandemic Impact on the Psychophysical Health of Post-Menopausal Women: A Cross-Sectional Study 144
Totale 21.879
Categoria #
all - tutte 76.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.606 242 106 142 219 220 153 75 195 86 125 533 510
2022/20233.168 276 484 158 415 227 258 85 174 568 84 297 142
2023/20241.219 87 151 52 90 116 211 69 135 34 70 119 85
2024/20254.011 124 523 276 252 773 190 183 133 76 351 262 868
2025/202611.264 1.822 922 781 615 925 492 823 285 1.764 755 613 1.467
2026/20271.067 1.067 0 0 0 0 0 0 0 0 0 0 0
Totale 30.006